Geode Capital Management »

Silverback Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $9.0M 877k 10.22
2023-09-30 $3.0M 803k 3.78
2023-06-30 $4.4M 654k 6.70
2023-03-31 $2.6M 404k 6.51
2022-12-31 $2.8M 332k 8.53
2022-09-30 $1.2M 224k 5.28
2022-06-30 $948k 224k 4.24
2022-03-31 $1.3M 363k 3.51
2021-12-31 $2.6M 392k 6.66
2021-09-30 $1.8M 185k 9.98
2021-06-30 $6.8M 221k 30.89
2021-03-31 $9.5M 219k 43.63
2020-12-31 $891k 19k 46.33